Progression Free and Overall Survival After Neoadjuvant Treatment of Colorectal Liver Metastases With Cetuximab Plus FOLFOX or FOLFIRI - Results of the CELIM Study

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Contributors

  • G. Folprecht - , Department of Internal Medicine I, TUD Dresden University of Technology, Indiana University Bloomington (Author)
  • T. Gruenberger - , University Hospital Vienna (Author)
  • W. Bechstein - , University Hospital Frankfurt (Author)
  • T. Lordick - , Dalhousie University (Author)
  • H. Lang - , Johannes Gutenberg University Mainz (Author)
  • J. Weitz - , Heidelberg University  (Author)
  • T. Suedhoff - , Dalhousie University (Author)
  • J. Hartmann - , Kiel University (Author)
  • T. Liersch - , University of Göttingen (Author)
  • C. Koehne - , Klinikum Oldenburg (Author)

Details

Original languageGerman
Pages (from-to)S394-S394
Number of pages1
JournalEuropean journal of cancer
Volume47
Publication statusPublished - Sept 2011
Peer-reviewedYes

Conference

TitleEuropean Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care
Duration23 - 27 September 2011
CityStockholm
CountrySweden

External IDs

ORCID /0000-0002-9321-9911/work/142252032

Keywords